Simian varicella virus infection of rhesus macaques recapitulates essential features of varicella zoster virus infection in humans

PLoS Pathogens

Volumn 5, Issue 11, 2009, Pages

  Messaoudi, Ilhem ^a   Barron, Alexander ^a   Wellish, Mary ^b   Engelmann, Flora ^a   Legasse, Alfred ^a   Planer, Shannon ^a   Gilden, Don ^b,c   Nikolich Zugich, Janko ^d   Mahalingam, Ravi ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS; CELLULAR IMMUNITY; CHICKENPOX; CONTROLLED STUDY; CYTOPLASM; DISEASE COURSE; FLOW CYTOMETRY; GANGLION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; INOCULATION; MALE; NERVE CELL; NONHUMAN; OPEN READING FRAME; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHESUS MONKEY; SEROLOGY; SIMIAN VARICELLA VIRUS; SIMIAN VIRUS; VARICELLA ZOSTER VIRUS; VIRUS DETECTION; VIRUS INFECTION; VIRUS LATENCY; VIRUS REACTIVATION; ANIMAL; B LYMPHOCYTE; CELL PROLIFERATION; DISEASE MODEL; GENETICS; HERPES VIRUS INFECTION; IMMUNOLOGY; MACACA; METABOLISM; PATHOGENICITY; PATHOLOGY; T LYMPHOCYTE; VARICELLOVIRUS; VIROLOGY; VIRUS LOAD;

ANIMALIA; CERCOPITHECINE HERPESVIRUS 9; HUMAN HERPESVIRUS 3; MACACA MULATTA; PRIMATES; SAL VIEJA VIRUS;

ANIMALS; B-LYMPHOCYTES; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DNA, VIRAL; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; MACACA MULATTA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; VARICELLOVIRUS; VIRAL LOAD;

EID: 73549118594     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000657     Document Type: Article

References (62)

1. Wroblewska Z, Devlin M, Reilly K, van Trieste H, Wellish M, et al. (1982) The production of varicella Zoster virus antiserum in laboratory animals. Brief report. Arch Virol 74: 233-238.
2. Felsenfeld AD, Schmidt NJ (1979) Varicella-zoster virus immunizes patas monkeys against simian varicella-like disease. J Gen Virol 42: 171-178.
3. Soike KF, Keller PM, Ellis RW (1987) Immunization of monkeys with varicellazoster virus glycoprotein antigens and their response to challenge with simian varicella virus. J Med Virol 22: 307-313.
4. Myers MG, Connelly BL (1992) Animal models of varicella. J Infect Dis 166 Suppl 1: S48-50.
5. Matsunaga Y, Yamanishi K, Takahashi M (1982) Experimental infection and immune response of guinea pigs with varicella-zoster virus. Infect Immun 37: 407-412.
6. Hayward AR, Burger R, Scheper R, Arvin AM (1991) Major histocompatibility complex restriction of T-cell responses to varicella-zoster virus in guinea pigs. J Virol 65: 1491-1495.
7. Ku C-C, Besser J, Abendroth A, Grose C, Arvin AM (2005) Varicella-Zoster Virus Pathogenesis and Immunobiology: New Concepts Emerging from Investigations with the SCIDhu Mouse Model. J Virol 79: 2651-2658.
8. Ku C-C, Zerboni L, Ito H, Graham BS, Wallace M, et al. (2004) Varicella-Zoster Virus Transfer to Skin by T Cells and Modulation of Viral Replication by Epidermal Cell Interferon-{alpha}. J Exp Med 200: 917-925.
9. Soike KF, Rangan SR, Gerone PJ (1984) Viral disease models in primates. Adv Vet Sci Comp Med 28: 151-199.
10. Pumphrey CY, Gray WL (1992) The genomes of simian varicella virus and varicella zoster virus are colinear. Virus Res 26: 255-266.
11. Gray WL, Starnes B, White MW, Mahalingam R (2001) The DNA sequence of the simian varicella virus genome. Virology 284: 123-130.
12. Gray WL (2004) Simian varicella: a model for human varicella-zoster virus infections. Rev Med Virol 14: 363-381.
13. Felsenfeld AD, Schmidt NJ (1975) Immunological relationship between delta herpesvirus of patas monkeys and varicells-zoster virus of humans. Infect Immun 12: 261-266.
14. Felsenfeld AD, Schmidt NJ (1977) Antigenic relationships among several simian varicella-like viruses and varicella-zoster virus. Infect Immun 15: 807-812.
15. Fletcher TM 3rd, Gray WL (1992) Simian varicella virus: characterization of virion and infected cell polypeptides and the antigenic cross-reactivity with varicella-zoster virus. J Gen Virol 73 (Pt 5): 1209-1215.
16. Kennedy PG, Grinfeld E, Traina-Dorge V, Gilden DH, Mahalingam R (2004) Neuronal localization of simian varicella virus DNA in ganglia of naturally infected African green monkeys. Virus Genes 28: 273-276.
17. Mahalingam R, Clarke P, Wellish M, Dueland AN, Soike KF, et al. (1992) Prevalence and distribution of latent simian varicella virus DNA in monkey ganglia. Virology 188: 193-197.
18. Mahalingam R, Smith D, Wellish M, Wolf W, Dueland AN, et al. (1991) Simian varicella virus DNA in dorsal root ganglia. Proc Natl Acad Sci U S A 88: 2750-2752.
19. Mahalingam R, Wellish M, Soike K, White T, Kleinschmidt-DeMasters BK, et al. (2001) Simian varicella virus infects ganglia before rash in experimentally infected monkeys. Virology 279: 339-342.
20. Kolappaswamy K, Mahalingam R, Traina-Dorge V, Shipley ST, Gilden DH, et al. (2007) Disseminated Simian Varicella Virus Infection in an Irradiated Rhesus Macaque (Macaca mulatta). J Virol 81: 411-415.
21. Mahalingam R, Traina-Dorge V, Wellish M, Lorino R, Sanford R, et al. (2007) Simian varicella virus reactivation in cynomolgus monkeys. Virology.
22. Schoeb TR, Eberle R, Black DH, Parker RF, Cartner SC (2008) Diagnostic exercise: papulovesicular dermatitis in rhesus macaques (Macaca mulatta). Vet Pathol 45: 592-594.
23. Dueland AN, Martin JR, Devlin ME, Wellish M, Mahalingam R, et al. (1992) Acute simian varicella infection. Clinical, laboratory, pathologic, and virologic features. Lab Invest 66: 762-773.
24. White TM, Mahalingam R, Traina-Dorge V, Gilden DH (2002) Simian varicella virus DNA is present and transcribed months after experimental infection of adult African green monkeys. J Neurovirol 8: 191-203.
25. White TM, Mahalingam R, Traina-Dorge V, Gilden DH (2002) Persistence of simian varicella virus DNA in CD4(+) and CD8(+) blood mononuclear cells for years after intratracheal inoculation of African green monkeys. Virology 303: 192-198.
26. Mahalingam R, Traina-Dorge V, Wellish M, Smith J, Gilden DH (2002) Naturally acquired simian varicella virus infection in African green monkeys. J Virol 76: 8548-8550.
27. Cohrs RJ, Gilden DH (2007) Prevalence and abundance of latently transcribed varicella-zoster virus genes in human ganglia. J Virol 81: 2950-2956.
28. Ou Y, Davis KA, Traina-Dorge V, Gray WL (2007) Simian varicella virus expresses a latency-associated transcript that is antisense to open reading frame 61 (ICP0) mRNA in neural ganglia of latently infected monkeys. J Virol 81: 8149-8156.
29. Mahalingam R, Wellish M, Cohrs R, Debrus S, Piette J, et al. (1996) Expression of protein encoded by varicella-zoster virus open reading frame 63 in latently infected human ganglionic neurons. Proc Natl Acad Sci U S A 93: 2122-2124.
30. Lungu O, Panagiotidis CA, Annunziato PW, Gershon AA, Silverstein SJ (1998) Aberrant intracellular localization of Varicella-Zoster virus regulatory proteins during latency. Proc Natl Acad Sci U S A 95: 7080-7085.
31. Arvin AM (2008) Humoral and Cellular Immunity to Varicella-Zoster Virus: An Overview. The Journal of Infectious Diseases 197: S58-S60.
32. Pitcher CJ, Hagen SI, Walker JM, Lum R, Mitchell BL, et al. (2002) Development and homeostasis of T cell memory in rhesus macaque. J Immunol 168: 29-43.
33. Bar-Or A, Oliveira EM, Anderson DE, Krieger JI, Duddy M, et al. (2001) Immunological memory: contribution of memory B cells expressing costimulatory molecules in the resting state. J Immunol 167: 5669-5677.
34. Messaoudi I, Warner J, Fischer M, Park B, Hill B, et al. (2006) Delay of T cell senescence by caloric restriction in aged long-lived nonhuman primates. Proc Natl Acad Sci U S A 103: 19448-19453.
35. Walker JM, Maecker HT, Maino VC, Picker LJ (2004) Multicolor flow cytometric analysis in SIV-infected rhesus macaque. Methods Cell Biol 75: 535-557.
36. Asanuma H, Sharp M, Maecker HT, Maino VC, Arvin AM (2000) Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression. J Infect Dis 181: 859-866.
37. Diaz PS, Smith S, Hunter E, Arvin AM (1989) T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine. J Immunol 142: 636-641.
38. Arvin AM (1992) Cell-mediated immunity to varicella-zoster virus. J Infect Dis 166 Suppl 1: S35-41.
39. Arvin AM, Sharp M, Moir M, Kinchington PR, Sadeghi-Zadeh M, et al. (2002) Memory cytotoxic T cell responses to viral tegument and regulatory proteins encoded by open reading frames 4, 10, 29, and 62 of varicella-zoster virus. Viral Immunol 15: 507-516.
40. Gray WL, Gusick NJ, Fletcher TM, Soike KF (1995) Simian varicella virus antibody response in experimental infection of African green monkeys. J Med Primatol 24: 246-251.
41. Gray WL, Williams RJ, Chang R, Soike KF (1998) Experimental simian varicella virus infection of St. Kitts vervet monkeys. J Med Primatol 27: 177-183.
42. Paiardini M, Pandrea I, Apetrei C, Silvestri G (2009) Lessons Learned from the Natural Hosts of HIV-Related Viruses. Annual Review of Medicine 60: 485-495.
43. Sodora DL, Allan JS, Apetrei C, Brenchley JM, Douek DC, et al. (2009) Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts. Nat Med 15: 861-865.
44. Mainka C, Fuss B, Geiger H, Hofelmayr H, Wolff MH (1998) Characterization of viremia at different stages of varicella-zoster virus infection. J Med Virol 56: 91-98.
45. de Jong MD, Weel JFL, Schuurman T, Wertheim-van Dillen PME, Boom R (2000) Quantitation of Varicella-Zoster Virus DNA in Whole Blood, Plasma, and Serum by PCR and Electrochemiluminescence. J Clin Microbiol 38: 2568-2573.
46. Ito Y, Kimura H, Hara S, Kido S, Ozaki T, et al. (2001) Investigation of varicella-zoster virus DNA in lymphocyte subpopulations by quantitative PCR assay. Microbiol Immunol 45: 267-269.
47. Cameron JC, Allan G, Johnston F, Finn A, Heath PT, et al. (2007) Severe complications of chickenpox in hospitalised children in the UK and Ireland. Arch Dis Child 92: 1062-1066.
48. Rivest P, Bedard L, Valiquette L, Mills E, Lebel MH, et al. (2001) Severe complications associated with varicella: Province of Quebec, April 1994 to March 1996. Can J Infect Dis 12: 21-26.
49. Beby-Defaux A, Brabant S, Chatellier D, Bourgoin A, Robert R, et al. (2009) Disseminated varicella with multiorgan failure in an immunocompetent adult. J Med Virol 81: 747-749.
50. Lee S, Ito N, Inagaki T, Okajima T, Muramatsu A, et al. (2004) Fulminant varicella infection complicated with acute respiratory distress syndrome, and disseminated intravascular coagulation in an immunocompetent young adult. Intern Med 43: 1205-1209.
51. Gray WL, Davis K, Ou Y, Ashburn C, Ward TM (2007) Simian varicella virus gene 61 encodes a viral transactivator but is non-essential for in vitro replication. Arch Virol 152: 553-563.
52. Arvin AM, Koropchak CM, Williams BR, Grumet FC, Foung SK (1986) Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection. J Infect Dis 154: 422-429.
53. Sharp M, Terada K, Wilson A, Nader S, Kinchington PE, et al. (1992) Kinetics and viral protein specificity of the cytotoxic T lymphocyte response in healthy adults immunized with live attenuated varicella vaccine. J Infect Dis 165: 852-858.
54. Sadzot-Delvaux C, Kinchington PR, Debrus S, Rentier B, Arvin AM (1997) Recognition of the latency-associated immediate early protein IE63 of varicellazoster virus by human memory T lymphocytes. J Immunol 159: 2802-2806.
55. Jones L, Black AP, Malavige GN, Ogg GS (2006) Persistent High Frequencies of Varicella-Zoster Virus ORF4 Protein-Specific CD4+ T Cells after Primary Infection. J Virol 80: 9772-9778.
56. Malavige GN, Jones L, Black AP, Ogg GS (2007) Rapid Effector Function of Varicella-Zoster Virus Glycoprotein I-Specific CD4 + T Cells Many Decades after Primary Infection. J Infect Dis 195: 660-664.
57. Malavige GN, Jones L, Black AP, Ogg GS (2008) Varicella zoster virus glycoprotein E-specific CD4+ T cells show evidence of recent activation and effector differentiation, consistent with frequent exposure to replicative cycle antigens in healthy immune donors. Clin Exp Immunol 152: 522-531.
58. Estep RD, Powers MF, Yen BK, Li H, Wong SW (2007) Construction of an infectious rhesus rhadinovirus bacterial artificial chromosome for the analysis of Kaposi's sarcoma-associated herpesvirus-related disease development. J Virol 81: 2957-2969.
59. White TM, Gilden DH, Mahalingam R (2001) An animal model of varicella virus infection. Brain Pathol 11: 475-479.
60. Jankovic V, Messaoudi I, Nikolich-Zugich J (2003) Phenotypic and functional Tcell aging in rhesus macaques (Macaca mulatta): differential behavior of CD4 and CD8 subsets. Blood 102: 3244-3251.
61. Ashburn CV, Gray WL (2002) Expression of the simian varicella virus glycoprotein L and H. Arch Virol 147: 335-348.
62. Ng TI, Keenan L, Kinchington PR, Grose C (1994) Phosphorylation of varicella-zoster virus open reading frame (ORF) 62 regulatory product by viral ORF 47-associated protein kinase. J Virol 68: 1350-1359.